Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/288
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Polycyclo ring system having the six-membered hetero ring as one of the cyclos > Tetracyclo ring system having the six-membered hetero ring as one of the cyclos > Plural hetero atoms in the tetracyclo ring system (e.g., acronycines, etc.) > Ring carbon is shared by three of the cyclos
Description: Subject matter wherein one ring carbon is a member of three of the cyclos in the tetracyclo ring system (i.e., peri-fusion).

Patents under this class:
1 2 3 4 5

Patent Number Title Of Patent Date Issued
8630703 Treatment utilizing hydrophobic weak bases chemotherapeutic agents and illumination Jan. 14, 2014
8613947 Bromocriptine formulations Dec. 24, 2013
8604035 Fluoroergoline analogs Dec. 10, 2013
8592445 Iso-ergoline derivatives Nov. 26, 2013
8592424 Topical regional neuro-affective therapy Nov. 26, 2013
8470844 Imidazoacridinone derivative compounds and methods for their use Jun. 25, 2013
8431155 Bromocriptine formulations Apr. 30, 2013
8404705 Naphthalene amidine imides Mar. 26, 2013
8338445 Crystal form of cabergoline Dec. 25, 2012
7713959 Compositions of an anticonvulsant and mirtazapine to prevent weight gain May. 11, 2010
7705013 Use of canthin-6-one, plant extracts containing same and derivatives thereof in the treatment of trypanosomiases Apr. 27, 2010
7666877 Ergoline derivatives Feb. 23, 2010
7632843 Treatment of psychostimulant addiction Dec. 15, 2009
7622476 Methods of using 1-allyl ergot alkaloid derivatives to treat migraines Nov. 24, 2009
7531551 Polymorphs of cabergoline May. 12, 2009
7144843 Pest controllers Dec. 5, 2006
7141582 Method for enhancing mutant enzyme activities in Gaucher disease Nov. 28, 2006
7081455 Substituted heterocycle fused gamma-carbolines Jul. 25, 2006
7071234 Methods of treating or preventing erectile dysfunction Jul. 4, 2006
6989390 Amonafide salts Jan. 24, 2006
6916829 Method for enhancing mutant enzyme activity in gaucher disease Jul. 12, 2005
6906040 Method for reducing toxicity of combined chemotherapies Jun. 14, 2005
6849619 Substituted pyridoindoles as serotonin agonists and antagonists Feb. 1, 2005
6844353 Fungicidal properties of sampangine and its analogs to agriculturally important fungal plant pathogens Jan. 18, 2005
6838456 Condensed pyridoindole derivatives Jan. 4, 2005
6800635 Crystalline form II of cabergoline Oct. 5, 2004
6777406 Substituted pyrroloquinolines and pyridoquinolines as serotinin agonists and antagonists Aug. 17, 2004
6777405 Detection and treatment of duplex polynucleotide damage Aug. 17, 2004
6727242 Pharmacological treatment for sleep apnea Apr. 27, 2004
6699852 Substituted pyridoindoles as serotonin agonists and antagonists Mar. 2, 2004
6680327 Crystalline form VII of cabergoline Jan. 20, 2004
6673806 Crystalline form II cabergoline Jan. 6, 2004
6664263 1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity Dec. 16, 2003
6608064 Pharmaceutical agents for the treatment of Parkinson's disease, ADHD and microadenomas Aug. 19, 2003
6572879 Formulations for transdermal delivery of pergolide Jun. 3, 2003
6559161 Cytotoxic pyrido[2,3,4-ki]acridine derivatives, their preparation and their therapeutic use May. 6, 2003
6555548 Compounds for treating fibromyalgia and chronic fatigue syndrome Apr. 29, 2003
6548493 Substituted heterocycle fused gamma-carbolines Apr. 15, 2003
6545011 Substituted 4,9-dihydrocyclopenta[imn]phenanthridine-5-ones, derivatives thereof and their uses Apr. 8, 2003
6503920 Cabergoline and pramipexole: new uses and combinations Jan. 7, 2003
6492332 Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation Dec. 10, 2002
6476021 Compounds having cGMP-PDE inhibitory effect Nov. 5, 2002
6469019 Therapeutic application of nicergoline Oct. 22, 2002
6444661 Detection and treatment of duplex polynucleotide damage Sep. 3, 2002
6403651 Mediation of circadian rhythms Jun. 11, 2002
6380267 Composition and method for decreasing neurologic symptomatology Apr. 30, 2002
6380208 Use of nicergoline for treating spasticity Apr. 30, 2002
6358967 Ergoline amine derivatives with blood pressure lowering effect Mar. 19, 2002
6346536 Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same Feb. 12, 2002
6331536 Pharmacological treatment for sleep apnea Dec. 18, 2001

1 2 3 4 5

  Recently Added Patents
Data converter with configurable functions
System and method for displaying relationships between electronically stored information to provide classification suggestions via inclusion
FET device having ultra-low on-resistance and low gate charge
Method of allocating IP address of image forming apparatus using DHCP, image forming apparatus and system of allocating IP address using DHCP
System and method for confirming delivery of an electronic message
Carrier for developing electrostatic charge image, developer for developing electrostatic charge image, image forming apparatus, and image forming method
Bezel-less electronic display
  Randomly Featured Patents
Releasibly locking demountable partitions and studs
Multichannel receiver system and method for multichannel receiver monitoring
Gel-forming mixture based on an alkali silicate and a trialkoxysilane
Pinch roller assembly for use in a video cassette recorder
Axial clearance adjustment mechanism for scroll type fluid displacement apparatus
In situ removal of contamination from soil
Multiple fan system having means for reducing beat frequency oscillations
Method for eliminating via resistance shift in organic ILD
Vinyl grafted lignite fluid loss additives
Shelving stand